10.01
-0.04(-0.40%)
Currency In USD
| Previous Close | 10.05 |
| Open | 10.15 |
| Day High | 10.38 |
| Day Low | 9.8 |
| 52-Week High | 18.9 |
| 52-Week Low | 9.34 |
| Volume | 2.75M |
| Average Volume | 2.44M |
| Market Cap | 977.84M |
| PE | -20.85 |
| EPS | -0.48 |
| Moving Average 50 Days | 11.62 |
| Moving Average 200 Days | 13.42 |
| Change | -0.04 |
If you invested $1000 in ARS Pharmaceuticals, Inc. (SPRY) since IPO date, it would be worth $400.4 as of October 20, 2025 at a share price of $10.01. Whereas If you bought $1000 worth of ARS Pharmaceuticals, Inc. (SPRY) shares 3 years ago, it would be worth $1,696.61 as of October 20, 2025 at a share price of $10.01.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
ARS Pharmaceuticals Receives Favorable Decision from European Patent Office on Patent Related to neffy® (epinephrine nasal spray)
GlobeNewswire Inc.
Oct 08, 2025 12:00 PM GMT
SAN DIEGO, Oct. 08, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a commercial-stage biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect patients from allergic reactions tha
neffy® (epinephrine nasal spray) Approved in Japan as the First and Only Needle-Free Emergency Treatment of Allergic Reactions (anaphylaxis)
GlobeNewswire Inc.
Sep 19, 2025 12:00 PM GMT
neffy 1 mg and 2 mg doses approved by Japanese regulators neffy offers a new delivery method for epinephrine in Japan for adults and children (>15 kg) living with severe allergic reactions Alfresa Holdings, which owns the rights to market neffy in Ja
Real-World Evidence Supports Clinical Effectiveness of neffy® (epinephrine nasal spray) in Patients Experiencing Anaphylaxis
GlobeNewswire Inc.
Sep 08, 2025 12:00 PM GMT
Findings accepted for publication in the official journal of the American College of Allergy, Asthma and Immunology About 9 out of every 10 patients experiencing anaphylaxis were effectively treated with a single dose of neffy Results suggest real-wo